Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-21-004949

Options or other derivatives

  • See Remarks acquired 269,390 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gould Robert J See Remarks 2021-02-02 Grant or award · Stock Option (right to buy) +269,390 269,390 D: show line 1 in the form
Loading xslF345X03/doc4.xml…